XML 116 R91.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity (Details) - USD ($)
shares in Millions
1 Months Ended 12 Months Ended
Feb. 23, 2021
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Shareholders' Equity (Details) [Line Items]        
Equity, description   The original authorized number of common shares was 1 share with a par value of $1.    
Statutory reserve, description   In addition, the Company’s subsidiaries incorporated in the PRC are required to annually appropriate 10% of their net income to the statutory reserve prior to payment of any dividends, unless the reserve has reached 50% of their respective registered capital.    
Statutory reserves  
Tax expense benefit    
Statutory Surplus [Member]        
Shareholders' Equity (Details) [Line Items]        
Statutory reserve, description   Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entity’s registered capital.    
Statutory reserves   $ 1,410,264 $ 970,009 $ 715,335
Restricted net amount (in Shares)   11,482,521 9,897,493  
Maxim Group LLC [Member]        
Shareholders' Equity (Details) [Line Items]        
Stockholder's equity stock split, description the Company entered into an agreement with Maxim Group LLC (“Maxim”) that Maxim will serves as a Placement Agent for the Company in connection with the proposed offering of registered securities of the Company, including shares of the Company’s common stock. On February 28, 2021, the Company entered into a securities purchase agreement (“SPA”) with certain accredited investors. According to the SPA, the Company agreed to sell 2,666,666 shares of the Company’s common stock and issue unregistered warrants to purchase up to an additional 2,666,666 shares of common stock in the concurrent private placement transaction (the transaction). On March 3, 2021, the Company issued 2,666,666 common shares at US$6.00 per share to those investors, with a par value of $0.0001 per share, and issued 2,666,666 warrants, generating total gross proceeds of $15,999,996. Net proceeds from the transaction after issuance cost of $1,317,119 were $14,682,877 which was allocated to common shares and warrants issued on their relative fair value basis of $11,131,829 and $3,551,048, respectively.